Diamond drilling by Tambourah Metals (ASX:TMB) at its namesake project in WA’s Pilbara region has returned bonanza-grade gold results and point to the Tambourah King prospect having strong potential to develop an initial resource estimate.
To read more, click here
Across Markets…
Australian shares rose on Thursday as sharp gains in technology and health stocks offset losses from a mixed session on Wall Street amid profit-taking after a fast start to the year for the S&P 500.
The benchmark S&P/ASX 200 Index added 0.3 per cent, or 25.2 points, to 8720.8 at the closing bell, with 10 of the 11 sectors in the green. Overnight on Wall Street, the S&P 500 was modestly lower in the final hour of the session despite resetting its record high earlier in the day.
The All Ordinaries rose by a similar amount.
On the ASX, the information technology sector was the best performing, climbing 1.7 per cent. WiseTech added 2.2 per cent to $68.28, Xero rose 0.7 per cent to $109.36 and TechnologyOne firmed 1.5 per cent to $27.60.
Healthcare stocks also recorded gains, with blood plasma giant CSL up 2.6 per cent to $174.45, Resmed adding 1.6 per cent to $37.10 and Ramsay Healthcare rising 2.2 per cent to $35.68.
In commodities, oil briefly traded below $US60 a barrel on the prospect of increased Venezuelan crude sales after US forces seized two more sanctioned tankers and said it was already marketing some of the country’s supply. Locally listed energy stocks Ampol and Beach Energy recorded losses of 0.9 per cent to $30.21 and 1.4 per cent to $1.07, respectively.
Elsewhere, gold and silver fell, dragging the wider materials sector lower. Gold miner Capricorn Metals dropped 5.8 per cent to $13.98 and St Barbara lost 3.4 per cent to 57¢. BHP, a mining giant with silver exposure, was off 0.8 per cent to $47.34.
Broker Goldman Sachs said investors should position for more volatility, paritcularly with silver. Swings in the price of silver were “likely” to persist, and volatility-averse investors should remain cautious, Goldman Sachs commodity strategists Lina Thomas and Daan Struyven wrote in a note.
“As long as silver remains dislocated in the US and liquidity in London is not restored with silver from elsewhere, prices could rise even further if investor enthusiasm persists,” they wrote.
In contrast, iron ore futures traded near $US109 a tonne in Singapore on hopes for more easing by China’s central bank to bolster the economy. Despite the rally, the mining giants were little changed.
Source: AFR
Hydrix secures $2.5m deal to collaborate on development of SynCardia’s total artificial heart technology
-
HYD inks $2.5m deal with SynCardia on Emperor.
-
Multi-stage; milestones tied to progress, safety, regs.
-
Hydrix to lead Emperor controller and subsystems.
Deep-tech product development company, Hydrix (ASX: HYD), has signed a contract with Picard Medical subsidiary SynCardia Systems to commence development on SynCardia’s next-generation Emperor fully-implantable total artificial heart technology.
The $2.5 million deal was secured through Hydrix’s wholly-owned subsidiary, Hydrix Services, and represents an initial project phase within a multi-stage and multi-year development program comprising defined engineering, verification, and regulatory milestones.
Advancement between stages is subject to technical progress and performance, safety validation, regulatory considerations and alignment, as well as SynCardia’s funding availability.
Global selection process
Hydrix was subject to a competitive global selection process with SynCardia which highlighted its experience in mechanical circulatory support systems and highly-regulated medical device development and a demonstrated track record in advancing complex, cardiovascular technologies.
The collaboration will encompass a ground-up system architecture, incorporating the company’s skills in electromechanical actuation, embedded software, energy management and safety-critical redundancy.
Hydrix will be tasked with developing Emperor’s controller, alongside various sub-system technologies using highly-specialised electronics, software, mechanical, usability and safety-critical design engineering disciplines.
Critical development
Hydrix executive chairman Gavin Coote said the contract strengthened the company’s position as a global partner of choice for complex, safety-critical cardiovascular technologies.
“We are excited to commence this critical development with SynCardia, a highly-regarded global leader in advanced heart replacement technology,” he said.
“It endorses our capacity to deliver complex, safety-critical medical device development programs for leading international medical technology companies.”
He said the companies would collaborate on a shared objective of developing transformative solutions for patients with advanced heart failure.
Source: SmallCaps
Company: Fin Resources Ltd (ASX:FIN)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.0065
Today’s Price Change: $0.011 Unchanged
Company: Locksley Resources Ltd (ASX:LKY)
Sector: REE & Antimony/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Today’s Price Change: $0.215 +10.26%
Company: CuFe Ltd (ASX:CUF)
Sector: Copper/Mining
Deal Type: Placement
Latest Entry Price: $0.016 with 1:2 option, strike $0.025
Today’s Price Change: $0.037 +12.12%
Company: Tasman Resources Ltd (ASX:TAS)
Sector: Gold/Silver/Mining
Deal Type: Placement
Latest Entry Price: $0.0125 with 1:2 option, strike $0.02
Today’s Price Change: $0.025 -3.85%
Company: Tambourah Metals Ltd (ASX:TMB)
Sector: Gold/Mining
Deal Type: Placement
Latest Entry Price: $0.04
Today’s Price Change: $0.055 +5.77%
Company: Biotron Ltd (ASX:BIT)
Sector: Biotech
Deal Type: Placement
Latest Entry Price: $0.003 with 1:2 option, strike $0.02
Today’s Price Change: $0.003 Unchanged
Company: Eclipse Metals Ltd (ASX:EPM)
Sector: REE
Deal Type: Placement
Latest Entry Price: $0.015
Today’s Price Change: $0.028 Unchanged
Company: Neuren Pharmaceuticals Ltd (ASX:NEU)
Sector: Biotech
Deal Type: On-market purchase
Latest Entry Price: $1.20 – $1.50
Today’s Price Change: $18.28 +2.63%
Company: Dimerix Ltd (ASX:DXB)
Sector: Biotech
Deal Type: Rights Issue
Raise Amount: $800,000
Latest Entry Price: $0.08 with 1:1 option, strike $0.126
Today’s Price Change: $0.535 -3.6%
Sector: Blockchain
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.02 with 1:1 option $0.08 strike
Today’s Price Change: $0.020 Unchanged
Company: Critica Limited (ASX:CRI)
Sector: REE
Deal Type: Placement
Raise Amount: $1M
Latest Entry Price: $0.0075 with a 1:1 CRIO
Today’s Price Change: $0.026 -7.14%
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.09 with 1:2 PL3O
Today’s Price Change: $0.085 +21.43%
Sector: Cybersecurity & AI
Deal Type: Placement
Raise Amount: $1.7M
Latest Entry Price: $0.01 with 1:3 option $0.02 strike
Today’s Price Change: $0.008 -11.11%
Sector: Gold/Mining
Deal Type: Placement
Raise Amount: $2.3M
Latest Entry Price: $0.026 with 1:2 option $0.032 strike
Today’s Price Change: $0.051 +2%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460

Comments are closed